The Swiss drugmaker said it would pay Nurix $700 million upfront, while development costs would be split 60-40, with Roche taking the larger share.
Source link
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
Date:
More like thisRelated
6 people hurt in stabbings at Penn Station, suspect in custody
Six people were injured in a stabbing inside New...
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate...
Former PRCA saddle bronc rider Shawn Tibbs passes away
Shawn Tibbs, a former PRCA saddle bronc rider, passed...
Israel strikes Iranian military targets hours after Tehran launched its own attacks
IE 11 is not supported. For an optimal experience...